Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

TG6050

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Transgene

Drug class:

CTLA4 inhibitor, Cell death stimulant, IL-12 stimulant

Related drugs:

‹

tavokinogene telsaplasmid (0)

ipilimumab (223)

tremelimumab (60)

cadonilimab (10)

iparomlimab/tuvonralimab (3)

ipilimumab biosimilar (CS1002) (2)

CTLA4 inhibitor (0)

IBI310 (ipilimumab biosimilar) (0)

prolgolimab/nurulimab (0)

PF-06753512 (0)

Ad-p53 gene therapy (0)

TRX-E-002-1 (0)

Clostridium novyi-NT (0)

synthetic hypericin (0)

ruxotemitide (0)

bendamustine hydrochloride (0)

ADV/IL-12 gene therapy (0)

Ad-RTS-hIL-12 (0)

tavokinogene telsaplasmid (0)

›